publication venue for
- The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective. 24:117-127. 2024
- The Cost Implications of Dabigatran in Patients with Myocardial Injury After Non-Cardiac Surgery. 22:83-91. 2022
- ACE Inhibitors in Heart Failure. 5:351-359. 2005
- Adjunctive Use of Direct Thrombin Inhibitors in Patients Receiving Fibrinolytic Therapy for Acute Myocardial Infarction. 4:107-115. 2004
- Failure of Aspirin to Prevent Atherothrombosis. 4:57-67. 2004
- New Anticoagulants. 3:201-209. 2003
- Cardiovascular Risk in Patients with Early Renal Insufficiency. 2:157-162. 2002
- Optimizing the Use of Abciximab and Intracoronary Stents in Patients with Acute ST Elevation Myocardial Infarction. 2:315-322. 2002
- Antiatherosclerotic Effects of ACE Inhibitors. 1:315-320. 2001
- Patient Self-Monitoring of Oral Anticoagulant Therapy. 1:245-251. 2001